New Deal
Ray Debbane
CEO at THE INVUS GROUP LLC
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Elevatebio
The Invus Group
£137m
24 dealmakers
ERASCA
Arch Venture Partners
£161m
22 dealmakers
Brius
value n/a
3 dealmakers
Cerevel Therapeutics
Ecor1 Capital
£1,002m
66 dealmakers
Kronos Bio
Perceptive Advisors
£118m
18 dealmakers
I-MAB
Hillhouse Capital Group
£315m
33 dealmakers
Element Science
£114m
13 dealmakers
Iteos Therapeutics
£101m
25 dealmakers
VISEON
Medfocus Fund
£13m
5 dealmakers
Thrive Earlier Detection Corp
Exact Sciences
£1,651m
Sqz Biotechnologies Company
Temasek Holdings
£53m
12 dealmakers
Lexicon Pharmaceuticals (xermelo Business)
Gtcr
£122m
41 dealmakers
Ikena Oncology
Omega Funds
£88m
15 dealmakers
Valo Health
Public Sector Pension Investment Board
£138m
8 dealmakers
Matrix Capital Management
£376m
Omega Therapeutics
Logos Capital
£91m
Presidio Medical
£22m
Generation Bio
Wellington Management
£83m
Repertoire Immune Medicines
Flagship Pioneering
17 dealmakers
AMOUNT
Barclays
6 dealmakers
Nikang Therapeutics
Surveyor Capital
£141m
29 dealmakers
Artios Pharma
Soleus Capital
£110m
EQRX
Bvf Partners
£2,622m
53 dealmakers
LARONDE
Federated Hermes Kaufmann Funds
£319m
9 dealmakers
Lexeo Therapeutics
D1 Capital Partners
£72m
BENEVOLENTAI
£1,282m
71 dealmakers
Senti Biosciences
Dynamics Special Purpose Corporation
£453m
42 dealmakers
Korro Bio
Atlas Venture
£85m
14 dealmakers
BOLT
Schonfeld Strategic Advisors
£259m
Evox Therapeutics
Orbimed Advisors
£69m
10 dealmakers
Moma Therapeutics
Rock Springs Capital
£121m
BOOSTER
Renewable Energy Group
£99m
16 dealmakers
SIRONAX
£163m
Pretzel Therapeutics
£62m
Neumora Therapeutics
HEMAB
Maj Invest Equity
£111m
Noema Pharma
Gilde Healthcare
£93m
19 dealmakers
Bicara Therapeutics
Premji Invest
£89m
BELLIWELLI
£12m
2 dealmakers
SEPTERNA
Ra Capital Management
£116m